We are live on ! Find out more
Jacobs Levy Equity Management

Jacobs Levy Equity Management Portfolio holdings

AUM $23.8B
1-Year Est. Return 25.4%
This Fund
S&P 500
This Quarter Est. Return
-1.9%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$4.72B
AUM Growth
-$313M
Cap. Flow
-$247M
Cap. Flow %
-5.24%
Top 10 Hldgs %
13.35%
Holding
1,246
New
455
Increased
271
Reduced
328
Closed
160

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$50.8M
2
DIS icon
Walt Disney
DIS
+$49.8M
3
ACN icon
Accenture
ACN
+$41.1M
4
BMY icon
Bristol-Myers Squibb
BMY
+$35.4M
5
VLO icon
Valero Energy
VLO
+$30.2M

Sector Composition

Rank Sector Weight
1 Technology 16.19%
2 Financials 16.07%
3 Healthcare 13.89%
4 Consumer Discretionary 12.13%
5 Industrials 9.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CTG
976
DELISTED
Computer Task Group, Inc.
CTG
$196K ﹤0.01%
38,266
+21,960
+135% +$122K
IVAC
977
DELISTED
Intevac Inc
IVAC
$189K ﹤0.01%
42,082
+1,166
+3% +$5.27K
XRM
978
DELISTED
Xerium Technologies Inc (new)
XRM
$187K ﹤0.01%
+35,800
New +$291K
GNW icon
979
Genworth Financial
GNW
$3.8B
$185K ﹤0.01%
+67,600
New +$171K
FRTX
980
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
$185K ﹤0.01%
151
-33
-18% -$38.1K
RYZ
981
Ryerson Holding Corp
RYZ
$1.6B
$183K ﹤0.01%
+32,827
New +$128K
REXX
982
DELISTED
Rex Energy Corporation
REXX
$183K ﹤0.01%
+23,860
New +$211K
ATI icon
983
ATI
ATI
$27B
$179K ﹤0.01%
+11,000
New +$134K
CCBG icon
984
Capital City Bank Group
CCBG
$882M
$178K ﹤0.01%
+12,167
New +$176K
HALO icon
985
Halozyme
HALO
$9.72B
$176K ﹤0.01%
+18,600
New +$175K
VIRX
986
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$173K ﹤0.01%
+1,527
New +$231K
TVPT
987
DELISTED
Travelport Worldwide Limited
TVPT
$173K ﹤0.01%
12,700
+600
+5% +$7.2K
HSTO
988
DELISTED
Histogen Inc. Common Stock
HSTO
$172K ﹤0.01%
+403
New +$156K
BHBK
989
DELISTED
Blue Hills Bancorp, Inc.
BHBK
$170K ﹤0.01%
+12,400
New +$174K
LNTH icon
990
Lantheus
LNTH
$6.82B
$168K ﹤0.01%
88,782
+46,595
+110% +$103K
KOPN icon
991
Kopin
KOPN
$663M
$165K ﹤0.01%
+99,300
New +$190K
LPSN icon
992
LivePerson
LPSN
$18.9M
$165K ﹤0.01%
+1,878
New +$155K
ATYR
993
aTyr Pharma
ATYR
$46.4M
$165K ﹤0.01%
+3,000
New +$228K
GI
994
DELISTED
EndoChoice Holdings, Inc.
GI
$165K ﹤0.01%
+31,750
New +$174K
NKTR icon
995
Nektar Therapeutics
NKTR
$2.39B
$163K ﹤0.01%
+792
New +$152K
CBIO
996
Crescent Biopharma
CBIO
$602M
$162K ﹤0.01%
273
-6
-2% -$3.08K
CNCE
997
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$162K ﹤0.01%
+11,840
New +$170K
CWEI
998
DELISTED
Clayton Williams Energy, Inc.
CWEI
$162K ﹤0.01%
+18,200
New +$266K
EVRI
999
DELISTED
Everi Holdings
EVRI
$161K ﹤0.01%
+70,300
New +$211K
VXRT
1000
DELISTED
Vaxart
VXRT
$161K ﹤0.01%
9,782
-3,607
-27% -$64.3K

Similar funds

Jacobs Levy Equity Management's Q1 2016 Portfolio in Review

As of Q1 2016, Jacobs Levy Equity Management held 1,246 positions worth $4.72B, down 6.2% from $5.03B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Jacobs Levy Equity Management withdrew a net $247M in Q1 2016, closing 160 positions and reducing 328 holdings. Its most notable exit was Merck, an estimated $50.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Jacobs Levy Equity Management opened a new position in Endo International plc worth $16.8M.

  • Jacobs Levy Equity Management's largest Q1 2016 buy was Endo International plc: 596,209 shares worth $16.8M.
  • Jacobs Levy Equity Management added most to Alphabet (Google) Class C in Q1 2016, an estimated $32.6M increase.
  • Jacobs Levy Equity Management's biggest Q1 2016 reduction was Walt Disney, cutting an estimated $49.8M.
  • Jacobs Levy Equity Management fully exited Merck in Q1 2016, selling an estimated $50.8M.
  • Jacobs Levy Equity Management's ten largest holdings make up 13% of its $4.72B portfolio in Q1 2016.
  • Jacobs Levy Equity Management opened 455 new positions and closed 160 in Q1 2016.
  • Jacobs Levy Equity Management's portfolio value fell 6.2% quarter-over-quarter to $4.72B.

Based on Jacobs Levy Equity Management's 13F filing for Q1 2016, filed 16 May 2016.